YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FBNQP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,113
Award facts
- Contract value 100% obligated
- $1,113.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $1,113.42 for YF-VAX 1 dose vials. Issued on September 2, 2025, with completion expected by September 23, 2025, this firm fixed-price delivery order represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status. The product—YF-VAX, a yellow fever vaccine—supports the medical supply requirements of Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award indefinite delivery contract with DLA valued at $499,999,999 and extending through November 2026. The parent contract, executed under the SPE2DB program, enables DLA to procure a comprehensive range of pharmaceutical products including prescription medications, biologics, vaccines, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group's sustained role as a critical pharmaceutical supplier to the federal government reflects its established capabilities in distributing both branded and generic pharmaceutical products to Defense Department healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FBNQP?
SPE2DB25FBNQP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FBNQP worth?
The government has obligated $1,113 on SPE2DB25FBNQP.
Is contract SPE2DB25FBNQP an order under another contract?
Yes. SPE2DB25FBNQP is a delivery order under SPE2DB24D9211, an indefinite delivery contract.
Was contract SPE2DB25FBNQP competed?
The extent of competition for SPE2DB25FBNQP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award